|
|
|
2008³â06¿ù04ÀÏ 00½Ã00ºÐ |
|
|
|
|
ÇѸ²ÀÇ´ë Á¶»óÈ£ ±³¼ö Ú¸ ÃÖ°í ±ÇÀ§ ÁßÀç½Ã¼ú °¡À̵å¶óÀÎ ÀÎ¿ë ±¹³»ÀÇÇÐÀÚ À¯ÀÏ |
|
ÇѸ²´ëÇб³ ÀÇ°ú´ëÇÐ ¼øȯ±â³»°ú Á¶»óÈ£ ±³¼ö ³í¹®ÀÌ ¹Ì±¹ ÃÖ°í ±ÇÀ§ÀÇ 3´ë ½ÉÀåºÐ¾ßÇÐȸ°¡ °øµ¿À¸·Î ÃâÆÇÇÑ ‘2007 ÁßÀç½Ã¼ú °¡À̵å¶óÀÎ’¿¡ ÀοëµÆ´Ù.
À̹ø¿¡ ÀοëµÈ ³í¹®Àº ‘Renal Toxicity Evaluation and Comparison Between Visipaqueâ (Iodixanol) and Hexabrixâ (Ioxaglate) in Patients With Renal Insufficiency Undergoing Coronary Angiography—The RECOVER Study: A Randomized Controlled Trial’À̶ó´Â ÀüÇâÀû ¹«ÀÛÀ§ ÀÓ»ó ¿¬±¸.
ÀÌ ³í¹®Àº ½Å±â´É ÀúÇÏ È¯ÀÚÀÇ °ü»óµ¿¸Æ ÁßÀç¼ú ½ÃÇà ½Ã Ç÷°ü Á¶¿µÁ¦ Áß iso-osmolar Á¶¿µÁ¦°¡ low-osmolar Á¶¿µÁ¦º¸´Ù ½Å±â´É º¸È£¿¡ ¿ì¼öÇÏ´Ù´Â ³»¿ëÀÌ´Ù.
ÀÌ ³í¹®Àº 2006³â ‘Journal of American College of Cardiology’(2007 impact factor 9.72)¿¡ óÀ½À¸·Î µîÀçµÆÀ¸¸ç, ¿ÃÇØ ÃâÆÇµÈ ¹Ì±¹ ½ÉÀåÇÐȸ, ½ÉÀåÇùȸ, °ü»óµ¿¸Æ ÁßÀç½Ã¼úÇÐȸ°¡ °øµ¿À¸·Î ÃâÆÇÇÑ ‘2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention’¿¡ ±¹³» ÀÇÇÐÀڷδ À¯ÀÏÇÏ°Ô ÀοëµÈ °ÍÀÌ´Ù.
¶Ç ÀÌ ³í¹®Àº Áö³ÇØ 10¿ù ¹ßÇ¥µÈ ½É±Ù°æ»ö, ºÒ¾ÈÁ¤ Çù½ÉÁõȯÀÚÀÇ Ä¡·á °¡ÀÌµå ¶óÀÎ(ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction)¿¡µµ ÀοëµÈ ¹Ù ÀÖ´Ù.
|
|
|
|
|
|